Israel China Biotechnology (ICB) Ltd (ICB) — Cash Flow Quality Index

Latest as of June 2021: -42.34x

Israel China Biotechnology (ICB) Ltd (ICB) has a Cash Flow Quality Index of -42.34x as of June 2021. Operating cash flow of ILA-1.06 Million is below net income of ILA25.00K, suggesting accrual-heavy earnings not yet converted to cash. Explore ICB long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

-42.34x

Operating CF / Net Income

Operating Cash Flow

ILA-1.06 Million

ILA

Net Income

ILA25.00K

ILA

Data as of

Jun 2021

Most recent filing

Annual Cash Flow Quality Index for Israel China Biotechnology (ICB) Ltd (None–None)

Year-by-year earnings quality comparison for Israel China Biotechnology (ICB) Ltd. For live market cap and the full company financial profile, see Israel China Biotechnology (ICB) Ltd (ICB) market capitalisation.

Year	Quality Index	Operating CF (ILA)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.